Boerne, TX, United States of America

Frederick H Hausheer

USPTO Granted Patents = 83 

 

 

Average Co-Inventor Count = 1.9

ph-index = 13

Forward Citations = 1,847(Granted Patents)


Inventors with similar research interests:


Location History:

  • Boerne, TX (US) (1999 - 2016)
  • Fair Oaks Ranch, TX (US) (2007 - 2019)
  • San Antonio, TX (US) (1993 - 2022)

Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
83 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Frederick H Hausheer - Pioneering Cancer Treatment Advancements

Introduction:

Frederick H Hausheer is a distinguished inventor from Boerne, TX (US) with a remarkable portfolio of 83 patents. His groundbreaking work in the field of oncology has significantly impacted cancer treatment methodologies, especially in cases of advanced ovarian cancer. Let's delve into the contributions and achievements of this prolific inventor.

Latest Patents:

Hausheer's recent patents include revolutionary treatments aimed at increasing cancer patient survival time. The administration of dithio-containing compounds, focusing on thioredoxin and glutaredoxin overexpression, has shown promising results in enhancing the effectiveness of chemotherapy interventions. Additionally, his work on Karenitecin for platinum and taxane chemotherapy-resistant ovarian cancer has opened new avenues for improving patient outcomes.

Career Highlights:

With a strong background in pharmaceuticals, Frederick H Hausheer has been a key figure at Bionumerik Pharmaceuticals, Inc. His expertise in developing innovative treatments for challenging medical conditions has been pivotal in shaping the landscape of cancer therapeutics. Hausheer's dedication to research and development has led to the successful implementation of novel pharmaceutical compositions that target specific cancer markers.

Collaborations:

Throughout his career, Hausheer has collaborated with esteemed professionals in the field of oncology. Notable coworkers include Kochat Haridas and Dhanabalan Murali, who have played integral roles in advancing cancer treatment methodologies alongside him. These collaborations have facilitated the exchange of ideas and expertise, leading to significant advancements in cancer research.

Conclusion:

Frederick H Hausheer's remarkable contributions to the field of oncology underscore his commitment to improving patient outcomes and advancing cancer treatment methodologies. His innovative approach to developing novel pharmaceutical compositions has set a new standard in personalized medicine, particularly for patients with advanced ovarian cancer. Hausheer's dedication to research and collaboration serves as an inspiration to aspiring inventors and underscores the profound impact that innovation can have on healthcare practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…